-transparent.png){kind=logo}
In 23 patients with HIV-associated Kaposi's sarcoma 53 tumor lesions were treated with fractioned radiotherapy. Indication for the radiotherapy were mostly cosmetic reasons in stigmatizing tumors, but also in several cases pain, oedema or functional deficits as a result of the tumor lesions. 21 patients received orthovoltage irradiation, the remaining four patients were treated with telecobalt therapy. A complete response was observed in 17%, a partial response in 76% and unchanged lesions in 4%. In two cases (4%), both were treated with telecobalt-therapy by large tumor masses, there occurred a further tumor progression inspite of the radiotherapy. In ten lesions, all with partial remission, we later observed a repeated tumor progression. Important side effects were signs of inflammation as mucositis and edema or hyperpigmentation. The occurrence of acute side effects can be reduced by fractionating of the radiotherapy.
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
January 1997,
Acta oncologica (Stockholm, Sweden),
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
January 1970,
South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
December 1991,
Zeitschrift fur arztliche Fortbildung,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
February 1999,
South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
January 1998,
Archives of pathology & laboratory medicine,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
April 1995,
Lancet (London, England),
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
October 2006,
Dermatologic clinics,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
January 2017,
Oncology research and treatment,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
February 2008,
Infection,
A Plettenberg, and
I Janik, and
H Kolb, and
W Meigel
January 1995,
Tumori,
